BeOne Medicines
ONC
#541
Rank
HK$364.46 B
Marketcap
HK$3,191
Share price
5.09%
Change (1 day)
24.63%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement